About the role
Celerion is committed to swift, exceptional clinical research through translational medicine. Every day, we use our experience, agility, and innovative research strategies to help get drugs to market faster.
Spoken Spanish-English bilingual fluency is required in our Call Center. In this role, you will answer inbound calls from members of the public interested in participating in our Phase 1 clinical drug trials. You will screen callers for study eligibility, and then collect and enter personal data for those eligible to participate. You will also make outbound calls to schedule appointments, as needed.
This is a Benefitted Full-Time role which works 40 hours per week. The Call Center operates Monday-Saturday.
Skills & Tags
Aplyr's read
Celerion excels in early clinical research, attracting professionals committed to advancing pharmacokinetics and pharmacodynamics for efficient drug development.
What's promising
- •Celerion offers specialized roles in pharmacokinetics and pharmacodynamics, appealing to niche scientific expertise.
- •The company is pivotal in early-stage drug development, providing critical data that accelerates market entry.
- •Celerion's global presence allows for diverse career opportunities in clinical research.
What to watch
- •Limited public information about career progression within the company.
- •Roles may require niche expertise, limiting opportunities for generalists.
- •Potential high-pressure environment due to the fast-paced nature of clinical trials.
Why Celerion
- •Celerion focuses on early clinical research, a critical phase in drug development.
- •The company emphasizes pharmacokinetics and pharmacodynamics, differentiating it from general clinical research firms.
- •Celerion's work directly impacts the efficiency of bringing new therapies to market.
Aplyr’s read is generated by AI from public sources. Was it useful?
About Celerion
Celerion is a leading provider of early clinical research services, specializing in pharmacokinetics and pharmacodynamics. They focus on delivering high-quality data to support drug development, helping clients bring new therapies to market more efficiently.
